ArticleFrontiers in pharmacology2025

Regulatory considerations for developing phage therapy medicinal products for the treatment of antimicrobial resistant bacterial infections.

Ai Fukaya-Shiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.